US biotechnology group Amgen has agreed to buy unlisted Decode Genetics, a pioneer in hunting down genes linked to disease, for… US biotechnology group Amgen has agreed to buy unlisted Decode Genetics ...

Institute researchers have developed a new multi-omics method enabling the profiling of multiple histone modifications and ...

Scientists at deCODE genetics, a subsidiary of Amgen, reveal today in Nature Genetics associations between rare loss-of-function variants in two genes and bipolar disorder. REYKJAVIK, Iceland, March ...

SAN FRANCISCO, California, USA, 8 July 2025 – In a comprehensive Genomic Press Interview published in Brain Medicine, Dr. Michael C. Oldham shares his unconventional journey from advertising executive ...

Chinese scientists have worked out a highly efficient tool to decode information in mammal's genome and hopefully to study more closely the mammalian life cycle, including causes for birth defects and ...

Now, a study published online Aug. 27 in the Proceedings of the National Academy of Sciences describes a new approach that allows researchers to decode the genome by understanding where genes begin to ...

Roche Holding extended its $5.7 billion cash bid for US gene decoder Illumina for a second time as the Swiss pharmaceutical firm sticks to its tried and tested M&A strategy. Roche is offering $44.50 ...

WASHINGTON - Will a gene bring healthful blessings or the curse of disease? It may depend on whether it is inherited from mom or dad, researchers reported on Wednesday. A team at Iceland's Decode ...

ZURICH (Reuters) - - Swiss drugmaker Roche wrote to Illumina investors directly on Tuesday and urged them to accept its $5.7 billion bid, arguing that the U.S. gene decoder faces pressure on revenue ...